Contract Pharma Manufacturing Services
-
Expertise, Experience, And Commitment Drives Results
2/28/2023
The BioCentriq team of experienced engineers, scientists, researchers, analysts, and operators have expertise in a variety of modalities, equipment, technologies, platforms, and processes.
-
Viral & Gene Therapy Manufacturing CDMO Services
6/15/2021
You’ve developed your viral vector gene therapy and now it’s time to embark on the voyage to manufacturing. But gene therapy production is uncharted territory, and you need someone to help navigate through the process. We can help.
-
AGCellerate For mAbs
6/29/2023
AGC Biologics has released a new program designed to deliver effective IND-ready GMP material for biopharmaceutical developers. AGCellerate offers guaranteed amounts at fixed timelines and costs –accelerating projects through development and into clinical phases.
-
Established, Robust, And Flexible Quality Management System
2/28/2023
BioCentriq has a comprehensive and established quality and compliance function with the personnel, systems, and procedures in place to apply phase-appropriate compliance and a quality-first approach to every program. Both Quality Assurance and Quality Control experts will be involved with your program from the very beginning as an integral part of the team starting with knowledge transfer and culminating with the release of your product.
-
Pharmaceutical Contract Packaging: Quality And Technologies
Our cutting-edge technology and impeccable standards ensure that our customers receive products that meet their exact needs.
-
Cell Line Development
1/25/2024
EirGenix provides comprehensive cell line development services from DNA replication to the generation of stable producer cell lines for further process development and manufacturing. Our goal is to assist our clients in identifying the most favorable cell line expression system and provide optimization to achieve or surpass expected project targets.
-
Modern GMP Manufacturing Suites, Pilot Plant, And Supporting Infrastructure
2/28/2023
BioCentriq owns and operates facilities that are designed exclusively for cell and gene therapy. All sites are fully equipped with standard equipment to manufacture autologous and allogeneic therapies using both open and closed processes. We have the quality systems and procedures in place to manufacture and release clinical grade material.
-
Building Robust, Flexible And Scalable Processes
2/28/2023
Learn more about BioCentriq’s manufacturing, science, and technology (MS&T) team, which uses a quality-by-design framework to serve as a hands-on liaison between partners and BioCentriq’s own process development and manufacturing teams.
-
Scale Your Vaccine With Path-To-PAD
3/1/2024
The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD (Process and Analytical Development) program provides a clear and easy path to maximize yields at the beginning of development, with deep expertise in vaccines, robust expression platforms, and high-quality Vero and Quail cell lines.
-
cGMP Manufacturing - Microbial System
1/25/2024
Learn how our 4,000-square-foot cGMP manufacturing site is purpose-built to support your microbial program from pre-clinical to commercial manufacturing.